eFFECTOR Therapeutics, Inc.
General ticker "EFTR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $0.9 (TTM average)
eFFECTOR Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -3.0%.
Estimated limits based on current volatility of 42.6%: low 0.00$, high 0.00$
Factors to consider:
- Total employees count: 15 (0.0%) as of 2023
- Top business risk factors: Economic downturns and volatility, Insufficient funding, Operating losses, Market competition, Intellectual property risks
- Current price 100.0% below estimated low
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [7.08$, 23.19$]
- 2024-12-30 to 2025-12-30 estimated range: [4.96$, 17.26$]
Financial Metrics affecting the EFTR estimates:
- Negative: with PPE of -0.6 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -125.85 <= 0.33
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 61.68 > -0.66
- Negative: Shareholder equity ratio, % of -28.21 <= 18.93
Short-term EFTR quotes
Long-term EFTR plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $1.43MM | $3.55MM | $0.00MM |
| Operating Expenses | $33.33MM | $35.96MM | $33.84MM |
| Operating Income | $-31.90MM | $-32.40MM | $-33.84MM |
| Non-Operating Income | $47.70MM | $9.74MM | $-1.97MM |
| Interest Expense | $1.76MM | $2.25MM | $2.92MM |
| R&D Expense | $19.96MM | $23.31MM | $22.92MM |
| Income(Loss) | $15.80MM | $-22.66MM | $-35.81MM |
| Profit(Loss)* | $15.80MM | $-12.93MM | $-35.81MM |
| Stockholders Equity | $17.28MM | $3.90MM | $-5.79MM |
| Inventory | $0.10MM | $0.03MM | $0.00MM |
| Assets | $54.06MM | $29.08MM | $20.54MM |
| Operating Cash Flow | $-24.89MM | $-25.90MM | $-29.55MM |
| Capital expenditure | $0.04MM | $0.19MM | $0.10MM |
| Investing Cash Flow | $0.56MM | $-17.86MM | $14.48MM |
| Financing Cash Flow | $58.81MM | $2.77MM | $21.23MM |
| Earnings Per Share** | $9.78 | $-7.85 | $-16.37 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.